Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

662662

registered interest
date	20/12/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	State Retirement Pensions: British Nationals Abroad
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will give an assurance to UK citizens living in the EU and in receipt of the UK basic state pension that they will continue to receive the annual pension increase when the UK leaves the EU.
tabling member printed	Lord Jones of Cheltenham
uin	HL4269
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>Negotiating the details of the UK’s exit will take some time. The status of pensioners will need careful consideration and state pensions will be considered as part of the negotiations.</p> answering member printed Lord Freud question first answered 21/12/2016 12:54:32 answering member 3893 label Biography information for Lord Freud
tabling member	248 label Biography information for Lord Jones of Cheltenham

662032

registered interest
date	19/12/2016
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Unmanned Air Vehicles
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they intend to remove restrictions on the acquisition of equipment by members of the public which is capable of disabling or destroying drones flying over their property.
tabling member printed	Lord Blencathra
uin	HL4202
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The Government recognises that an increase in the popularity of small drones, including those with cameras, raises a number of questions about privacy, safety, security, and data protection. Safety, security and privacy must always be the overriding priority and both commercial and leisure operators must operate drones responsibly within the rules.</p><p> </p><p>The Government is today launching a consultation to determine if further measures are needed in this area.</p> answering member printed Lord Ahmad of Wimbledon question first answered 21/12/2016 13:38:32 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
tabling member	497 label Biography information for Lord Blencathra

662033

registered interest
date	19/12/2016
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Unmanned Air Vehicles
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by the Minister of State for Transport on 10 September 2015 (HC7971), what action the cross-government working group has taken to reduce the risks posed by drones to civil aviation; and whether they plan to consult on the introduction of new criminal offences relating to (1) causing a nuisance, (2) endangering persons on the ground, and (3) endangering aircraft, through use of a drone.
tabling member printed	Lord Blencathra
uin	HL4203
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>We have been working closely with the Civil Aviation Authority and industry to adapt and strengthen regulations and implement mitigations as drones use and the related technology evolves. This has led to a new safety awareness campaign aimed at leisure drone users. So far, this has included the launch of a new <a href="http://www.dronesafe.uk" target="_blank">www.dronesafe.uk</a> website, a #400ftBritain drone photography competition that highlights safety rules, and a free new app ‘Drone Assist’ by NATS, which shows users where they should and should not fly in their locality. There are already offences to deter and, if necessary, prosecute operators for malicious or negligent use, including a prison sentence of up to five years for endangering an aircraft.</p><p> </p><p>The Government is today launching a consultation to determine if further measures are needed in this area.</p> answering member printed Lord Ahmad of Wimbledon question first answered 21/12/2016 13:46:47 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
tabling member	497 label Biography information for Lord Blencathra

662066

registered interest
date	19/12/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Disadvantaged
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the proposed green paper on Social Justice will give consideration to the enactment of section 1 of the Equality Act 2010.
tabling member printed	Baroness Lister of Burtersett
uin	HL4234
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The Prime Minister is clear that tackling poverty and disadvantage, and delivering real social reform, is a priority for this Government.</p><p> </p><p>The Department for Work and Pensions is leading work across Government to bring forward a social justice green paper in the New Year. This will identify and address the root causes of poverty, building upon the two statutory indicators set out in the Welfare Reform and Work Act 2016.</p> answering member printed Lord Freud question first answered 21/12/2016 13:54:12 answering member 3893 label Biography information for Lord Freud
tabling member	4234 label Biography information for Baroness Lister of Burtersett

662068

registered interest
date	19/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Per Capita Costs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the ranking of spending on healthcare per capita amongst EU member states.
tabling member printed	Lord Moonie
uin	HL4236
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The latest Organisation for Economic Co-operation and Development (OECD) figures for total, per capita expenditure on healthcare that have been provided by the countries themselves are for 2014. These figures are only available for the 22 European Union member states that are also members of the OECD. They indicate that the United Kingdom ranked 10<sup>th</sup> out of 22 for total, per capita expenditure on healthcare in 2014. Rankings for all 22 EU member states that are also members of the OECD can be found in Table 1.</p><p> </p><p>OECD estimates for 2015 from their ‘Health at a Glance: Europe 2016’ report suggest that the United Kingdom’s ranking remains unchanged at 10<sup>th</sup> out of all 28 EU member states and that total, per capita expenditure on healthcare is slightly above the EU28 average. However, these figures are yet to be verified by the United Kingdom and a further 19 countries in the report.</p><p> </p><p> </p><p> </p><p>Table 1: Per capita expenditure on healthcare by the 22 EU member states that are also members of the OECD in 2014 - all functions, all financing schemes and all providers (current prices and current purchasing power parity)</p><table><tbody><tr><td><p>Country</p></td><td><p>Rank - 2014</p></td></tr><tr><td><p>Austria</p></td><td><p>6</p></td></tr><tr><td><p>Belgium</p></td><td><p>8</p></td></tr><tr><td><p>Czech Republic</p></td><td><p>16</p></td></tr><tr><td><p>Denmark</p></td><td><p>7</p></td></tr><tr><td><p>Estonia</p></td><td><p>20</p></td></tr><tr><td><p>Finland</p></td><td><p>11</p></td></tr><tr><td><p>France</p></td><td><p>9</p></td></tr><tr><td><p>Germany</p></td><td><p>3</p></td></tr><tr><td><p>Greece</p></td><td><p>17</p></td></tr><tr><td><p>Hungary</p></td><td><p>19</p></td></tr><tr><td><p>Ireland</p></td><td><p>5</p></td></tr><tr><td><p>Italy</p></td><td><p>12</p></td></tr><tr><td><p>Latvia</p></td><td><p>22</p></td></tr><tr><td><p>Luxembourg</p></td><td><p>1</p></td></tr><tr><td><p>Netherlands</p></td><td><p>2</p></td></tr><tr><td><p>Poland</p></td><td><p>21</p></td></tr><tr><td><p>Portugal</p></td><td><p>15</p></td></tr><tr><td><p>Slovak Republic</p></td><td><p>18</p></td></tr><tr><td><p>Slovenia</p></td><td><p>14</p></td></tr><tr><td><p>Spain</p></td><td><p>13</p></td></tr><tr><td><p>Sweden</p></td><td><p>4</p></td></tr><tr><td><p>United Kingdom</p></td><td><p>10</p></td></tr></tbody></table><p> </p><p>Source: OECD.Stat, Health Expenditure and Financing, 2014.</p> answering member printed Lord Prior of Brampton question first answered 21/12/2016 13:57:47 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	621 label Biography information for Lord Moonie

662093

registered interest
date	19/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuroblastoma
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they plan to uphold the verdict of the National Institute for Health and Clinical Excellence with regard to dinutuximab for children with neuroblastoma.
tabling member printed	Baroness Masham of Ilton
uin	HL4261
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published its final guidance on dinutuximab (Unituxin) as a maintenance treatment after therapy for high-risk neuroblastoma. NICE’s Appraisal Committee is currently considering its draft guidance in light of the Appeal Panel’s decision to uphold an appeal against its final appraisal determination.</p><p> </p><p>Dinutuximab was referred to NICE under the single technology appraisal programme following its consideration through the established topic selection process including a public consultation and a scoping workshop with stakeholders.</p><p> </p><p>NICE is also currently appraising another anti-GD2 antibody product, APN311, for use in the treatment of high-risk neuroblastoma. APN311 is not yet licensed for use in the United Kingdom and has only been available in the UK in clinical trials.</p><p> </p><p>Neither treatment has been routinely commissioned for National Health Service patients in England.</p> answering member printed Lord Prior of Brampton grouped question UIN HL4262 HL4263 question first answered 21/12/2016 13:55:28 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1850 label Biography information for Baroness Masham of Ilton

662094

registered interest
date	19/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuroblastoma
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government why dinutuximab was referred to the National Institute for Health and Clinical Excellence under the Single Technology Appraisal methodology and not the Highly Specialised Technology programme.
tabling member printed	Baroness Masham of Ilton
uin	HL4262
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published its final guidance on dinutuximab (Unituxin) as a maintenance treatment after therapy for high-risk neuroblastoma. NICE’s Appraisal Committee is currently considering its draft guidance in light of the Appeal Panel’s decision to uphold an appeal against its final appraisal determination.</p><p> </p><p>Dinutuximab was referred to NICE under the single technology appraisal programme following its consideration through the established topic selection process including a public consultation and a scoping workshop with stakeholders.</p><p> </p><p>NICE is also currently appraising another anti-GD2 antibody product, APN311, for use in the treatment of high-risk neuroblastoma. APN311 is not yet licensed for use in the United Kingdom and has only been available in the UK in clinical trials.</p><p> </p><p>Neither treatment has been routinely commissioned for National Health Service patients in England.</p> answering member printed Lord Prior of Brampton grouped question UIN HL4261 HL4263 question first answered 21/12/2016 13:55:28 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1850 label Biography information for Baroness Masham of Ilton

662095

registered interest
date	19/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuroblastoma
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to restore the availability of, and access to, the anti-GD2 antibody which had previously been approved.
tabling member printed	Baroness Masham of Ilton
uin	HL4263
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published its final guidance on dinutuximab (Unituxin) as a maintenance treatment after therapy for high-risk neuroblastoma. NICE’s Appraisal Committee is currently considering its draft guidance in light of the Appeal Panel’s decision to uphold an appeal against its final appraisal determination.</p><p> </p><p>Dinutuximab was referred to NICE under the single technology appraisal programme following its consideration through the established topic selection process including a public consultation and a scoping workshop with stakeholders.</p><p> </p><p>NICE is also currently appraising another anti-GD2 antibody product, APN311, for use in the treatment of high-risk neuroblastoma. APN311 is not yet licensed for use in the United Kingdom and has only been available in the UK in clinical trials.</p><p> </p><p>Neither treatment has been routinely commissioned for National Health Service patients in England.</p> answering member printed Lord Prior of Brampton grouped question UIN HL4261 HL4262 question first answered 21/12/2016 13:55:28 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	1850 label Biography information for Baroness Masham of Ilton

660106

registered interest
date	16/12/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Carers: Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what steps he is taking to support people providing unpaid care in securing and keeping (a) full-time and (b) part-time employment.
tabling member constituency	Glasgow East
tabling member printed	Natalie McGarry
uin	58002
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>Carer’s Allowance is paid to informal carers who meet the qualifying conditions, which include being over the age of 16 and providing care for at least 35 hours a week for a person with a disability who is in receipt of a qualifying benefit. Over 785,000 carers in Great Britain, including around 70,000 in Scotland, currently receive Carer’s Allowance. Carer’s Allowance can be claimed online, and around three quarters of carers submit their claims this way. Since the online service was launched, nearly 700,000 claims have been made this way, with feedback from claimants showing that more than nine out of ten are satisfied with the service. Financial support for carers is also available through Universal Credit, Income Support, Housing Benefit and Pension Credit.</p><p> </p><p>As more employers understand the value of retaining their employees, and as flexible working becomes more widely available, it is increasingly important to allow carers to balance their caring responsibilities with paid employment. To help with this we will be publishing proposals on carers’ employment in our Fuller Working Lives Strategy in the new year; rolling out Universal Credit to ensure work pays for all people, including carers; and increasing the earnings limit in Carer’s Allowance from £110 to £116 a week from April 2017.</p> answering member constituency Portsmouth North answering member printed Penny Mordaunt grouped question UIN 58003 question first answered 21/12/2016 13:30:54 answering member 4017 label Biography information for Penny Mordaunt
tabling member	4428 label Biography information for Natalie McGarry

660107

registered interest
date	16/12/2016
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Social Security Benefits: Carers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what steps he is taking to ensure that adult and young carers who provide unpaid care receive the carer's allowance and other benefits they are entitled to.
tabling member constituency	Glasgow East
tabling member printed	Natalie McGarry
uin	58003
answer	answer is ministerial correction date of answer 21/12/2016 answer text <p>Carer’s Allowance is paid to informal carers who meet the qualifying conditions, which include being over the age of 16 and providing care for at least 35 hours a week for a person with a disability who is in receipt of a qualifying benefit. Over 785,000 carers in Great Britain, including around 70,000 in Scotland, currently receive Carer’s Allowance. Carer’s Allowance can be claimed online, and around three quarters of carers submit their claims this way. Since the online service was launched, nearly 700,000 claims have been made this way, with feedback from claimants showing that more than nine out of ten are satisfied with the service. Financial support for carers is also available through Universal Credit, Income Support, Housing Benefit and Pension Credit.</p><p> </p><p>As more employers understand the value of retaining their employees, and as flexible working becomes more widely available, it is increasingly important to allow carers to balance their caring responsibilities with paid employment. To help with this we will be publishing proposals on carers’ employment in our Fuller Working Lives Strategy in the new year; rolling out Universal Credit to ensure work pays for all people, including carers; and increasing the earnings limit in Carer’s Allowance from £110 to £116 a week from April 2017.</p> answering member constituency Portsmouth North answering member printed Penny Mordaunt grouped question UIN 58002 question first answered 21/12/2016 13:30:54 answering member 4017 label Biography information for Penny Mordaunt
tabling member	4428 label Biography information for Natalie McGarry